[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595212":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":41,"responsibleParty":61,"collaborators":63,"id":66,"slug":26,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":26,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":26,"enrollmentInfo":74,"targetDuration":26,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":85,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Wooshin Labottach Co., Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"EXPERIMENTAL COSMETIC","EXPERIMENTAL","APPLICATION OF THE EXPERIMENTAL PATCH WITH COSMETIC",[13],"Other: Cosmetic patch containing urea applicated daily for 3 months",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Application of the Placebo patch",[19],"Other: Placebo patch application",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"OTHER","Cosmetic patch containing urea applicated daily for 3 months","Daily application of the patch on toes, 3 months treatment",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo patch application","Daily application of a placebo patch on toes for a 3 months treatment",[15],[32,37],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Adolfo Gasparetto","CONTACT","+393356641965","adolfogasparetto@nextrasearch.it",{"name":38,"role":34,"phone":39,"phoneExt":26,"email":40},"Andrea Borgatta","+393472644870","andreaborgatta@nextrasearch.it",[42],{"facility":43,"status":44,"city":45,"state":26,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Clinica Dermatologica - Policlinico - Università degli Studi di Milano Via Francesco Sforza- Milano","RECRUITING","Milan","20122","Italy",{"type":49,"coordinates":50},"Point",[51,52],12.59836,42.78235,{"lat":52,"lon":51},[55,59],{"name":56,"role":34,"phone":57,"phoneExt":26,"email":58},"Paolo Bortoluzzi, Phd","+393494182187","paolo.bortoluzzi@policninico.mi.it",{"name":56,"role":60,"phone":26,"phoneExt":26,"email":26},"PRINCIPAL_INVESTIGATOR",{"type":62,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[64],{"name":65,"class":22},"Nextrasearch S.r.l.s.","100595212",false,"NCT07029516","Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis","A Randomized, Double Blind, Placebo-controlled, Unicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of a Multi-funtion Toe Nail Patch in Patients Affected by Nail Fragility, Nail Mychosis and Psoriasis","Inclusion Criteria:\n\n* aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator.\n\nExclusion Criteria:\n\n* Patients that have proximal subungual onychomycosis, if their distal subungual onychomycosis is extended into the proximal portion of the nail or if it affects \\>75% of the nail.\n* Patients with conditions known to cause abnormal nail appearance, immunosuppression and signs of severe peripheral circulatory insufficiency\n* Patients who had used topical antifungal, anti-psoriasis nail treatment within one month or systemic antifungal treatment within three months.\n* Patients who have participated in another clinical nail study during the previous three months\n* Patients who have a known allergy to any of the study treatments.\n* Patients with unrelated nail disorders: onychomycosis, nail psoriasis, genetically induced onychodystrophy.\n* Patients with other nail disorders, active or severe psoriasis elsewhere, other autoimmune or inflammatory diseases.","ALL","18 Years",{"count":75,"type":76},72,"ESTIMATED","INTERVENTIONAL",[79],"PHASE3","A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up",[82,83,84],"Nail Psoriasis","Nail Damage","Mycosis",[86,87,88,89],"ONICOMYCOSIS","PATCH","UREA","PSORIASIS","2026-01-22",{"date":92,"type":93},"2026-01-26","ACTUAL",{"date":95,"type":76},"2026-02",{"date":97,"type":76},"2026-12",{"name":5,"class":6},1]